Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson’s disease patients

作者: Paul J Lucassen , Anne-Marie van Dam , Karlijn J Doorn , Tim Moors , Benjamin Drukarch

DOI: 10.1186/S40478-014-0090-1

关键词:

摘要: Next to α-synuclein deposition, microglial activation is a prominent pathological feature in the substantia nigra (SN) of Parkinson’s disease (PD) patients. Little known, however, about different phenotypes microglia and how they change during progression, SN or another brain region, like hippocampus (HC), which implicated dementia depression, important non-motor symptoms PD. We studied HC established PD patients (Braak stage 4–6), matched controls 0) incidental Lewy Body (iLBD) cases 1–3) that are considered prodromal state As recent experimental studies suggested toll-like receptor 2 (TLR2) mediates triggered activation, we also whether TLR2 expression indeed related pathology iLBD A clear pathology-related increase amoeboid was present Also, morphologically primed/reactive cells, profound were apparent iLBD, but not PD, cases, indicative an early activational response pathology. Moreover, differentially expressed between HC, consistent with region-specific pattern activation. In conclusion, regional changes phenotype indicate may play role microglial-mediated responses could be for progression.

参考文章(67)
Fiona Thomson, Parkinson's Disease Neuron. ,vol. 39, pp. 889- 909 ,(2003) , 10.1016/S0896-6273(03)00568-3
Joana B. Pereira, Carme Junqué, David Bartrés-Faz, Blanca Ramírez-Ruiz, Maria-Jose Marti, Eduardo Tolosa, Regional Vulnerability of Hippocampal Subfields and Memory Deficits in Parkinson's Disease Hippocampus. ,vol. 23, pp. 720- 728 ,(2013) , 10.1002/HIPO.22131
Karlijn J. Doorn, Andrea Goudriaan, Carla Blits-Huizinga, John G.J.M. Bol, Annemieke J. Rozemuller, Piet V.J.M. Hoogland, Paul J. Lucassen, Benjamin Drukarch, Wilma D.J. van de Berg, Anne-Marie van Dam, Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients. Brain Pathology. ,vol. 24, pp. 152- 165 ,(2014) , 10.1111/BPA.12088
Non-dopamine lesions in Parkinson's disease In: Halliday, G and PhD, and Barker, R and MRCP, and Rowe, D and Fracp, , (eds.) Non-Dopamine Lesions in Parkinson's Disease. (? - ?). Oxford Univ Pr (2010). ,(2010) , 10.1093/MED/9780195371086.001.0001
Aidan Lyncaro, New York '98 Torquere. ,vol. 3, ,(1969) , 10.25071/1488-5182.36616
D. M. Norden, J. P. Godbout, Review: Microglia of the aged brain: primed to be activated and resistant to regulation Neuropathology and Applied Neurobiology. ,vol. 39, pp. 19- 34 ,(2013) , 10.1111/J.1365-2990.2012.01306.X
Malabendu Jana, Carlos A. Palencia, Kalipada Pahan, Fibrillar Amyloid-β Peptides Activate Microglia via TLR2: Implications for Alzheimer’s Disease Journal of Immunology. ,vol. 181, pp. 7254- 7262 ,(2008) , 10.4049/JIMMUNOL.181.10.7254
Stefanie Frank, Guido J. Burbach, Michael Bonin, Michael Walter, Wolfgang Streit, Ingo Bechmann, Thomas Deller, TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia. ,vol. 56, pp. 1438- 1447 ,(2008) , 10.1002/GLIA.20710
F.C. Joelving, R. Billeskov, J.R. Christensen, M. West, B. Pakkenberg, Hippocampal neuron and glial cell numbers in Parkinson's disease--a stereological study. Hippocampus. ,vol. 16, pp. 826- 833 ,(2006) , 10.1002/HIPO.20212